Today: 27 June 2026
ASX 200 Falls Again as Oil Shock Splits Australia Stock Market Before RBA Test
24 April 2026
2 mins read

ASX 200 Falls Again as Oil Shock Splits Australia Stock Market Before RBA Test

SYDNEY, April 24, 2026, 17:25 AEST

Australian stocks notched a fourth consecutive decline on Friday, with the S&P/ASX 200 edging down 6.9 points, or roughly 0.1%, to finish at 8,786.5. The All Ordinaries index slipped 0.2% to 9,006.4. Over the last five sessions, the benchmark has dropped 1.8%.

This shift is significant: worries have spilled beyond global jitters. Crude holding above $105 a barrel is now weighing on Australia’s shares, feeding into expectations for interest rates. Investors are watching for March inflation numbers, out April 29, ahead of the Reserve Bank of Australia’s 2:30 p.m. policy call on May 5.

Instead of a broad selloff, investors favored a rotation. Defensive sectors like utilities, energy, and consumer staples proved resilient, clinging to steady gains. Basic materials, industrials, and real estate, however, took the brunt of the slide, according to ABC market data.

Brent crude hovered near $105.48 a barrel late in Sydney, with U.S. crude holding around $95.96. Persistent gridlock in the Strait of Hormuz continued to stoke fuel-security concerns. On Wall Street, the S&P 500 ended down 0.4%, while the Nasdaq shed 0.9% overnight.

Vishnu Varathan, who heads macro strategy for APAC at Mizuho, told Reuters that expecting a “linear de-escalation” in violence, oil prices, or volatility would be misguided. According to Varathan, investors are still positioning on the chance the crisis might resolve soon, but hardly anyone is relying on that outcome as their main scenario. Reuters

Energy stocks stood out. “Markets are pricing a meaningful supply risk premium,” said Jimmy Tran, dealing manager at Moomoo, noting about 20% of global oil flows through the Strait of Hormuz. If prices remain high, Woodside, Santos, and Beach Energy could gain, he added. Indo Premier

Suncorp shares rallied, closing up 4.9% at A$17.12 after the insurer secured a five-year aggregate reinsurance cover. The deal brings A$800 million in annual protection—A$2.4 billion total over five years, according to Suncorp. Reinsurance, which insurers use to offset major claims, was at the heart of the move.

Suncorp’s acting chief executive Jeremy Robson said the new cover should deliver “reduced volatility in earnings.” The company put out a forecast for gross written premium growth of roughly 3% for fiscal 2026. Gross written premium refers to the total premium income an insurer books, before subtracting reinsurance and other costs.

Miners dragged the index lower. Shares in IGO plunged 17.3% to A$7.06 after the company slashed its fiscal 2026 production forecast for Greenbushes spodumene, now expecting 1,375-1,425 kilotonnes instead of the earlier 1,500-1,650 kilotonnes, and also raised its unit cash-cost estimate.

The decline followed IGO’s report that its average realised spodumene price jumped to $1,668 a tonne—almost twice as high. Greenbushes posted a 75% EBITDA margin. EBITDA stands for earnings before interest, tax, depreciation and amortisation; it’s widely used as an indicator of operating profit, stripped of certain costs.

On the Sydney exchange, 609 stocks declined while 489 advanced, according to Investing.com. Summerset Group, Suncorp, and Austal stood out among top ASX 200 gainers. On the flip side, IGO, EVT, and Contact Energy posted the session’s steepest drops.

There’s a real chance the trade flips fast. If tensions in the Middle East ease, oil might slide and energy stocks could cool off. On the flip side, another fuel price jump—or a higher CPI next week—would squeeze rate-sensitive areas like real estate, zeroing traders in on the RBA’s call in May.

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Stock Market Today

  • Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted
    June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified by the Fast Growing Stocks With High Insider Ownership screener, highlighting firms with aligned management-shareholder interests amid mixed inflation and cautious central bank policies.

Latest articles

Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

27 June 2026
Snowflake Inc (NYSE:SNOW) surged 9.65% to $248.96 on Friday with trading volume five times the weekly average, driven by FTSE Russell’s U.S. index reconstitution, turning a negative week into a 7.2% gain since June 18, as investors await whether the stock can hold above its previous $225.95–$230.41 range when index-driven liquidity fades next week.
GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
FTSE 100 Falls Today as Oil Surge and Trump Tariff Threat Shake London Stocks
Previous Story

FTSE 100 Falls Today as Oil Surge and Trump Tariff Threat Shake London Stocks

Atomera Stock Jumps Nearly 50% After Synopsys Deal Puts GaN Chip Tech in Focus
Next Story

Atomera Stock Jumps Nearly 50% After Synopsys Deal Puts GaN Chip Tech in Focus

Go toTop